Delivery Order SPE2DR25D2002-SPE2DR26FBSG4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $10,744.44. This is a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive capability in federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a contract ceiling value of $4,000.44. This is a firm fixed price delivery order with an ultimate completion date of November 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on June 2, 2025, with a ceiling value of $1,501.50 and an ultimate completion date of June 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $3,466.72 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The product will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's corporate headquarters and primary distribution center for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens in 0.5 ml doses, with a ceiling value of $13,305.28 and a firm fixed price structure. This non-competitive delivery order is scheduled for completion by December 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $3,856.80. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 12, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,790.18 on December 4, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with an ultimate completion date of December 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,162.96 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on December 9, 2025, with completion scheduled for December 10, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical supply transaction under the company's existing indefinite delivery contract with DLA Troop Support Medical. The award is not designated as a set-aside contract and will be performed at...
- The Defense Logistics Agency awarded a $11,940.80 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,453.70 on November 18, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens with an ultimate completion date of November 19, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, AmerisourceBergen's headquarters location. This delivery order is a...
- SPE2DR25D2002Indefinite Delivery Contract
- SPE2DR25D2002-SPE2DR26FBSG4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $1,453.70. This is a firm fixed-price delivery order with an ultimate completion date of December 2, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply contract supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio with DLA demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies that support the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/30/25 |